Genetic Therapies for the Final 10%: What’s Coming Into Focus
For years, the potential for development of genetic therapy has been a source of cautious hope for the cystic fibrosis (CF) community—especially for those in... Read More
GRANTS WE FUND
EE has awarded millions of dollars to multi-disciplinary teams around the world to advance research and drug development for the final 10% of people with CF.
CLINICAL TRIALS
Our cystic fibrosis clinical trial matchmaking program is direct-to-consumer, making trial recruitment faster, more targeted, and more efficient.
PATIENT DATABASE
Emily’s Entourage CF Clinical Trial Connect (CTC) is the only global patient database exclusively for people with CF who are unable to benefit from CFTR modulators. By joining, you can help accelerate the development of new, lifesaving CF therapies.
Advancing CF Science: Emily’s Entourage Announces New 2025 Research Grants
EE Awards Research Grants to Fuel Innovation for the Final 10% Emily’s Entourage is proud to announce the 2025 recipients of our Translational Research Grants—four... Read More
Glitter and Grit: Finding Hope Through Art and Cystic Fibrosis
During CF Awareness Month, Emily’s Entourage invites members of the cystic fibrosis (CF) community to share their stories. Today’s post features Dylan Mortimer—an artist and... Read More
CF Before Birth: How One Couple Used Modulators for In Utero Treatment to Improve Health Outcomes for Their Child
During CF Awareness Month, Emily’s Entourage invites members of the CF community to share their stories. Today’s blog post features Chris and Erica Molaro, a... Read More